Global Intravenous Solutions (Colloids) Market Growth 2025-2031

January 2025 | 94 pages | ID: G0885ECFD82EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Intravenous Solutions (Colloids) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.

LP Information, Inc. (LPI) ' newest research report, the “Intravenous Solutions (Colloids) Industry Forecast” looks at past sales and reviews total world Intravenous Solutions (Colloids) sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Solutions (Colloids) sales for 2025 through 2031. With Intravenous Solutions (Colloids) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Solutions (Colloids) industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Solutions (Colloids) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Solutions (Colloids) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Solutions (Colloids) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Solutions (Colloids) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Solutions (Colloids).

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions (Colloids) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Peripheral Parenteral Nutrition
• Total Parenteral Nutrition

Segmentation by Application:

• Hospital and Clinics
• Ambulatory
• Home Care

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• ICU Medical Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Baxter
• Amanta Healthcare
• Terumo Medical Corporation
• Grifols S.A.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Solutions (Colloids) market?

What factors are driving Intravenous Solutions (Colloids) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Solutions (Colloids) market opportunities vary by end market size?

How does Intravenous Solutions (Colloids) break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intravenous Solutions (Colloids) Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Intravenous Solutions (Colloids) by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Intravenous Solutions (Colloids) by Country/Region, 2020, 2024 & 2031
2.2 Intravenous Solutions (Colloids) Segment by Type
  2.2.1 Peripheral Parenteral Nutrition
  2.2.2 Total Parenteral Nutrition
2.3 Intravenous Solutions (Colloids) Sales by Type
  2.3.1 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2020-2025)
  2.3.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Intravenous Solutions (Colloids) Sale Price by Type (2020-2025)
2.4 Intravenous Solutions (Colloids) Segment by Application
  2.4.1 Hospital and Clinics
  2.4.2 Ambulatory
  2.4.3 Home Care
2.5 Intravenous Solutions (Colloids) Sales by Application
  2.5.1 Global Intravenous Solutions (Colloids) Sale Market Share by Application (2020-2025)
  2.5.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Intravenous Solutions (Colloids) Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Intravenous Solutions (Colloids) Breakdown Data by Company
  3.1.1 Global Intravenous Solutions (Colloids) Annual Sales by Company (2020-2025)
  3.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Company (2020-2025)
3.2 Global Intravenous Solutions (Colloids) Annual Revenue by Company (2020-2025)
  3.2.1 Global Intravenous Solutions (Colloids) Revenue by Company (2020-2025)
  3.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Company (2020-2025)
3.3 Global Intravenous Solutions (Colloids) Sale Price by Company
3.4 Key Manufacturers Intravenous Solutions (Colloids) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Intravenous Solutions (Colloids) Product Location Distribution
  3.4.2 Players Intravenous Solutions (Colloids) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INTRAVENOUS SOLUTIONS (COLLOIDS) BY GEOGRAPHIC REGION

4.1 World Historic Intravenous Solutions (Colloids) Market Size by Geographic Region (2020-2025)
  4.1.1 Global Intravenous Solutions (Colloids) Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Intravenous Solutions (Colloids) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Intravenous Solutions (Colloids) Market Size by Country/Region (2020-2025)
  4.2.1 Global Intravenous Solutions (Colloids) Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Intravenous Solutions (Colloids) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravenous Solutions (Colloids) Sales Growth
4.4 APAC Intravenous Solutions (Colloids) Sales Growth
4.5 Europe Intravenous Solutions (Colloids) Sales Growth
4.6 Middle East & Africa Intravenous Solutions (Colloids) Sales Growth

5 AMERICAS

5.1 Americas Intravenous Solutions (Colloids) Sales by Country
  5.1.1 Americas Intravenous Solutions (Colloids) Sales by Country (2020-2025)
  5.1.2 Americas Intravenous Solutions (Colloids) Revenue by Country (2020-2025)
5.2 Americas Intravenous Solutions (Colloids) Sales by Type (2020-2025)
5.3 Americas Intravenous Solutions (Colloids) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intravenous Solutions (Colloids) Sales by Region
  6.1.1 APAC Intravenous Solutions (Colloids) Sales by Region (2020-2025)
  6.1.2 APAC Intravenous Solutions (Colloids) Revenue by Region (2020-2025)
6.2 APAC Intravenous Solutions (Colloids) Sales by Type (2020-2025)
6.3 APAC Intravenous Solutions (Colloids) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Intravenous Solutions (Colloids) by Country
  7.1.1 Europe Intravenous Solutions (Colloids) Sales by Country (2020-2025)
  7.1.2 Europe Intravenous Solutions (Colloids) Revenue by Country (2020-2025)
7.2 Europe Intravenous Solutions (Colloids) Sales by Type (2020-2025)
7.3 Europe Intravenous Solutions (Colloids) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intravenous Solutions (Colloids) by Country
  8.1.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Country (2020-2025)
8.2 Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2020-2025)
8.3 Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Solutions (Colloids)
10.3 Manufacturing Process Analysis of Intravenous Solutions (Colloids)
10.4 Industry Chain Structure of Intravenous Solutions (Colloids)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Intravenous Solutions (Colloids) Distributors
11.3 Intravenous Solutions (Colloids) Customer

12 WORLD FORECAST REVIEW FOR INTRAVENOUS SOLUTIONS (COLLOIDS) BY GEOGRAPHIC REGION

12.1 Global Intravenous Solutions (Colloids) Market Size Forecast by Region
  12.1.1 Global Intravenous Solutions (Colloids) Forecast by Region (2026-2031)
  12.1.2 Global Intravenous Solutions (Colloids) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Intravenous Solutions (Colloids) Forecast by Type (2026-2031)
12.7 Global Intravenous Solutions (Colloids) Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 ICU Medical Inc.
  13.1.1 ICU Medical Inc. Company Information
  13.1.2 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 ICU Medical Inc. Main Business Overview
  13.1.5 ICU Medical Inc. Latest Developments
13.2 B. Braun Melsungen AG
  13.2.1 B. Braun Melsungen AG Company Information
  13.2.2 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 B. Braun Melsungen AG Main Business Overview
  13.2.5 B. Braun Melsungen AG Latest Developments
13.3 Fresenius Kabi AG
  13.3.1 Fresenius Kabi AG Company Information
  13.3.2 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Fresenius Kabi AG Main Business Overview
  13.3.5 Fresenius Kabi AG Latest Developments
13.4 Baxter
  13.4.1 Baxter Company Information
  13.4.2 Baxter Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Baxter Main Business Overview
  13.4.5 Baxter Latest Developments
13.5 Amanta Healthcare
  13.5.1 Amanta Healthcare Company Information
  13.5.2 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Amanta Healthcare Main Business Overview
  13.5.5 Amanta Healthcare Latest Developments
13.6 Terumo Medical Corporation
  13.6.1 Terumo Medical Corporation Company Information
  13.6.2 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Terumo Medical Corporation Main Business Overview
  13.6.5 Terumo Medical Corporation Latest Developments
13.7 Grifols S.A.
  13.7.1 Grifols S.A. Company Information
  13.7.2 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolios and Specifications
  13.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Grifols S.A. Main Business Overview
  13.7.5 Grifols S.A. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Intravenous Solutions (Colloids) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Intravenous Solutions (Colloids) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peripheral Parenteral Nutrition
Table 4. Major Players ofTotal Parenteral Nutrition
Table 5. Global Intravenous Solutions (Colloids) Sales byType (2020-2025) & (K Units)
Table 6. Global Intravenous Solutions (Colloids) Sales Market Share byType (2020-2025)
Table 7. Global Intravenous Solutions (Colloids) Revenue byType (2020-2025) & ($ million)
Table 8. Global Intravenous Solutions (Colloids) Revenue Market Share byType (2020-2025)
Table 9. Global Intravenous Solutions (Colloids) Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Intravenous Solutions (Colloids) Sale by Application (2020-2025) & (K Units)
Table 11. Global Intravenous Solutions (Colloids) Sale Market Share by Application (2020-2025)
Table 12. Global Intravenous Solutions (Colloids) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2020-2025)
Table 14. Global Intravenous Solutions (Colloids) Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Intravenous Solutions (Colloids) Sales by Company (2020-2025) & (K Units)
Table 16. Global Intravenous Solutions (Colloids) Sales Market Share by Company (2020-2025)
Table 17. Global Intravenous Solutions (Colloids) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Intravenous Solutions (Colloids) Revenue Market Share by Company (2020-2025)
Table 19. Global Intravenous Solutions (Colloids) Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Intravenous Solutions (Colloids) Producing Area Distribution and Sales Area
Table 21. Players Intravenous Solutions (Colloids) Products Offered
Table 22. Intravenous Solutions (Colloids) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Intravenous Solutions (Colloids) Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Intravenous Solutions (Colloids) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Intravenous Solutions (Colloids) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Intravenous Solutions (Colloids) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Intravenous Solutions (Colloids) Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Intravenous Solutions (Colloids) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Intravenous Solutions (Colloids) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Intravenous Solutions (Colloids) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 34. Americas Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2025)
Table 35. Americas Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Intravenous Solutions (Colloids) Sales byType (2020-2025) & (K Units)
Table 37. Americas Intravenous Solutions (Colloids) Sales by Application (2020-2025) & (K Units)
Table 38. APAC Intravenous Solutions (Colloids) Sales by Region (2020-2025) & (K Units)
Table 39. APAC Intravenous Solutions (Colloids) Sales Market Share by Region (2020-2025)
Table 40. APAC Intravenous Solutions (Colloids) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Intravenous Solutions (Colloids) Sales byType (2020-2025) & (K Units)
Table 42. APAC Intravenous Solutions (Colloids) Sales by Application (2020-2025) & (K Units)
Table 43. Europe Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 44. Europe Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Intravenous Solutions (Colloids) Sales byType (2020-2025) & (K Units)
Table 46. Europe Intravenous Solutions (Colloids) Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Intravenous Solutions (Colloids) Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Intravenous Solutions (Colloids)
Table 52. Key Market Challenges & Risks of Intravenous Solutions (Colloids)
Table 53. Key IndustryTrends of Intravenous Solutions (Colloids)
Table 54. Intravenous Solutions (Colloids) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Intravenous Solutions (Colloids) Distributors List
Table 57. Intravenous Solutions (Colloids) Customer List
Table 58. Global Intravenous Solutions (Colloids) SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Intravenous Solutions (Colloids) RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Intravenous Solutions (Colloids) SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Intravenous Solutions (Colloids) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Intravenous Solutions (Colloids) SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Intravenous Solutions (Colloids) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Intravenous Solutions (Colloids) SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Intravenous Solutions (Colloids) RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Intravenous Solutions (Colloids) SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Intravenous Solutions (Colloids) RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Intravenous Solutions (Colloids) SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Intravenous Solutions (Colloids) RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Intravenous Solutions (Colloids) SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Intravenous Solutions (Colloids) RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ICU Medical Inc. Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 73. ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 74. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. ICU Medical Inc. Main Business
Table 76. ICU Medical Inc. Latest Developments
Table 77. B. Braun Melsungen AG Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 78. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 79. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. B. Braun Melsungen AG Main Business
Table 81. B. Braun Melsungen AG Latest Developments
Table 82.Fresenius Kabi AG Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 83.Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 84.Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85.Fresenius Kabi AG Main Business
Table 86.Fresenius Kabi AG Latest Developments
Table 87. Baxter Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 88. Baxter Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 89. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Baxter Main Business
Table 91. Baxter Latest Developments
Table 92. Amanta Healthcare Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 93. Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 94. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Amanta Healthcare Main Business
Table 96. Amanta Healthcare Latest Developments
Table 97.Terumo Medical Corporation Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 98.Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 99.Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100.Terumo Medical Corporation Main Business
Table 101.Terumo Medical Corporation Latest Developments
Table 102. Grifols S.A. Basic Information, Intravenous Solutions (Colloids) Manufacturing Base, Sales Area and Its Competitors
Table 103. Grifols S.A. Intravenous Solutions (Colloids) Product Portfolios and Specifications
Table 104. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Grifols S.A. Main Business
Table 106. Grifols S.A. Latest Developments



LIST OFFIGURES

Figure 1. Picture of Intravenous Solutions (Colloids)
Figure 2. Intravenous Solutions (Colloids) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Solutions (Colloids) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Intravenous Solutions (Colloids) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Intravenous Solutions (Colloids) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Intravenous Solutions (Colloids) Sales Market Share by Country/Region (2024)
Figure 10. Intravenous Solutions (Colloids) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Peripheral Parenteral Nutrition
Figure 12. Product Picture ofTotal Parenteral Nutrition
Figure 13. Global Intravenous Solutions (Colloids) Sales Market Share byType in 2025
Figure 14. Global Intravenous Solutions (Colloids) Revenue Market Share byType (2020-2025)
Figure 15. Intravenous Solutions (Colloids) Consumed in Hospital and Clinics
Figure 16. Global Intravenous Solutions (Colloids) Market: Hospital and Clinics (2020-2025) & (K Units)
Figure 17. Intravenous Solutions (Colloids) Consumed in Ambulatory
Figure 18. Global Intravenous Solutions (Colloids) Market: Ambulatory (2020-2025) & (K Units)
Figure 19. Intravenous Solutions (Colloids) Consumed in Home Care
Figure 20. Global Intravenous Solutions (Colloids) Market: Home Care (2020-2025) & (K Units)
Figure 21. Global Intravenous Solutions (Colloids) Sale Market Share by Application (2024)
Figure 22. Global Intravenous Solutions (Colloids) Revenue Market Share by Application in 2025
Figure 23. Intravenous Solutions (Colloids) Sales by Company in 2025 (K Units)
Figure 24. Global Intravenous Solutions (Colloids) Sales Market Share by Company in 2025
Figure 25. Intravenous Solutions (Colloids) Revenue by Company in 2025 ($ millions)
Figure 26. Global Intravenous Solutions (Colloids) Revenue Market Share by Company in 2025
Figure 27. Global Intravenous Solutions (Colloids) Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Intravenous Solutions (Colloids) Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Intravenous Solutions (Colloids) Sales 2020-2025 (K Units)
Figure 30. Americas Intravenous Solutions (Colloids) Revenue 2020-2025 ($ millions)
Figure 31. APAC Intravenous Solutions (Colloids) Sales 2020-2025 (K Units)
Figure 32. APAC Intravenous Solutions (Colloids) Revenue 2020-2025 ($ millions)
Figure 33. Europe Intravenous Solutions (Colloids) Sales 2020-2025 (K Units)
Figure 34. Europe Intravenous Solutions (Colloids) Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Intravenous Solutions (Colloids) Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Intravenous Solutions (Colloids) Revenue 2020-2025 ($ millions)
Figure 37. Americas Intravenous Solutions (Colloids) Sales Market Share by Country in 2025
Figure 38. Americas Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2025)
Figure 39. Americas Intravenous Solutions (Colloids) Sales Market Share byType (2020-2025)
Figure 40. Americas Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2025)
Figure 41. United States Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Intravenous Solutions (Colloids) Sales Market Share by Region in 2025
Figure 46. APAC Intravenous Solutions (Colloids) Revenue Market Share by Region (2020-2025)
Figure 47. APAC Intravenous Solutions (Colloids) Sales Market Share byType (2020-2025)
Figure 48. APAC Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2025)
Figure 49. China Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 53. India Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Intravenous Solutions (Colloids) Sales Market Share by Country in 2025
Figure 57. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2025)
Figure 58. Europe Intravenous Solutions (Colloids) Sales Market Share byType (2020-2025)
Figure 59. Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2025)
Figure 60. Germany Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 61.France Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2025)
Figure 68. Egypt Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Intravenous Solutions (Colloids) Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Intravenous Solutions (Colloids) in 2025
Figure 74. Manufacturing Process Analysis of Intravenous Solutions (Colloids)
Figure 75. Industry Chain Structure of Intravenous Solutions (Colloids)
Figure 76. Channels of Distribution
Figure 77. Global Intravenous Solutions (Colloids) Sales MarketForecast by Region (2026-2031)
Figure 78. Global Intravenous Solutions (Colloids) Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Intravenous Solutions (Colloids) Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Intravenous Solutions (Colloids) Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Intravenous Solutions (Colloids) Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Intravenous Solutions (Colloids) Revenue Market ShareForecast by Application (2026-2031)